Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet.
OBJECTIVE
To investigate the influences of red mold rice (RMR) on obesity and related metabolic abnormalities.


RESULTS
The 3T3-L1 cell line was used to examine the effects of RMR extracts on preadipocytes and on mature adipocytes. Both water and ethanol extracts of RMR had inhibitory effects on 3T3-L1 preadipocyte proliferation and differentiation. Water extracts of RMR enhanced the lipolysis activity in mature adipocytes, which negatively correlated with the triglyceride content within cells. RMR treatment did not affect heparin-releasable lipoprotein lipase activity in mature adipocytes. Furthermore, animal studies were carried out to explore the antiobesity effects of RMR. The control group of male Wistar rats were fed regular laboratory feed, whereas the other groups were fed the high-fat (HF) diet supplemented with lovastatin, rice or RMR (0.4 and 2%, w w(-1)). The relative caloric intakes of the control and HF groups were 3.34 and 4.85 kcal g(-1), respectively. After 6 weeks, rats treated with RMR at the 0.4 and 2% doses had lower weight gain and less fat pads mass accompanied with smaller fat cells than did the HF-diet rats. These effects probably resulted from an increase in the lipolysis activity of adipose tissue and a reduction in food/energy consumption. On the other hand, the RMR supplement significantly reduced serum total cholesterol, serum low-density lipoprotein (LDL) cholesterol, the ratio of LDL to high-density lipoprotein (HDL) cholesterol and serum insulin in the HF group. Moreover, the 2% RMR treatment significantly increased serum HDL cholesterol.


CONCLUSIONS
This study reveals for the first time that RMR can prevent body fat accumulation and improve dyslipidemia. The antiobesity effects of RMR mainly derive from the lipolytic activity and mild antiappetite potency of RMR. In addition, extracts of RMR suppressed the proliferation and differentiation in 3T3-L1 preadipocytes, which might have contributed to the inhibition of new adipocyte formation or hyperplasia in adipose tissue.
Chen
W-P
WP
Institute of Microbiology and Biochemistry, College of Life Science, National Taiwan University, Taipei, Taiwan.
Ho
B-Y
BY
Lee
C-L
CL
Lee
C-H
CH
Pan
T-M
TM
D041721:3T3-L1 Cells / Q000378:metabolism; D017667:Adipocytes / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D019587:Dietary Supplements; D050171:Dyslipidemias / Q000378:metabolism / Q000517:prevention & control; D006946:Hyperinsulinism / Q000378:metabolism / Q000517:prevention & control; D008297:Male; D051379:Mice; D032741:Monascus / Q000737:chemistry; D009765:Obesity / Q000378:metabolism / Q000517:prevention & control*; D012275:Oryza; D008517:Phytotherapy; D028321:Plant Preparations / Q000627:therapeutic use*; D051381:Rats
D019440:Anti-Obesity Agents; D028321:Plant Preparations